Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Influence of collagen source on fibrillar architecture and properties of vitrified collagen membranes.

Majumdar S, Guo Q, Garza-Madrid M, Calderon-Colon X, Duan D, Carbajal P, Schein O, Trexler M, Elisseeff J.

J Biomed Mater Res B Appl Biomater. 2015 Mar 12. doi: 10.1002/jbm.b.33381. [Epub ahead of print]

PMID:
25766399
2.

Sentinel Events, Serious Reportable Events, and Root Cause Analysis.

Chen TC, Schein OD, Miller JW.

JAMA Ophthalmol. 2015 Mar 5. doi: 10.1001/jamaophthalmol.2015.0672. [Epub ahead of print] No abstract available.

PMID:
25742139
3.

Regeneration of corneal epithelium utilizing a collagen vitrigel membrane in rabbit models for corneal stromal wound and limbal stem cell deficiency.

Chae JJ, Ambrose WM, Espinoza FA, Mulreany DG, Ng S, Takezawa T, Trexler MM, Schein OD, Chuck RS, Elisseeff JH.

Acta Ophthalmol. 2015 Feb;93(1):e57-66. doi: 10.1111/aos.12503. Epub 2014 Dec 11.

PMID:
25495158
4.

Application of a collagen-based membrane and chondroitin sulfate-based hydrogel adhesive for the potential repair of severe ocular surface injuries.

Chae JJ, Mulreany DG, Guo Q, Lu Q, Choi JS, Strehin I, Espinoza FA, Schein O, Trexler MM, Bower KS, Elisseeff JH.

Mil Med. 2014 Jun;179(6):686-94. doi: 10.7205/MILMED-D-13-00360.

PMID:
24902138
5.

Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair.

Guo Q, Phillip JM, Majumdar S, Wu PH, Chen J, Calderón-Colón X, Schein O, Smith BJ, Trexler MM, Wirtz D, Elisseeff JH.

Biomaterials. 2013 Dec;34(37):9365-72. doi: 10.1016/j.biomaterials.2013.08.061. Epub 2013 Sep 13.

PMID:
24041426
6.

Author reply: To PMID 22749087.

Gottsch J, Schein O.

Ophthalmology. 2013 Mar;120(3):654. doi: 10.1016/j.ophtha.2012.11.034. No abstract available.

PMID:
23714619
7.

1. History, evolution, and evolving standards of contact lens care.

Szczotka-Flynn L, Ahearn DG, Barr J, Benjamin WJ, Kiang T, Nichols JJ, Schein OD, Stone RP, Winterton L.

Cont Lens Anterior Eye. 2013 Jan 15;36 Suppl 1:S4-8. doi: 10.1016/S1367-0484(13)60003-X.

PMID:
23347574
8.

Letter to the editor: multicenter case-control study of the role of lens materials and care products on the development of corneal infiltrates.

Katz J, Schein O.

Optom Vis Sci. 2013 Feb;90(2):e79. doi: 10.1097/OPX.0b013e3182851c6c. No abstract available.

PMID:
23353993
9.

Cataract surgery among Medicare beneficiaries.

Schein OD, Cassard SD, Tielsch JM, Gower EW.

Ophthalmic Epidemiol. 2012 Oct;19(5):257-64. doi: 10.3109/09286586.2012.698692.

10.

Structure and properties of collagen vitrigel membranes for ocular repair and regeneration applications.

Calderón-Colón X, Xia Z, Breidenich JL, Mulreany DG, Guo Q, Uy OM, Tiffany JE, Freund DE, McCally RL, Schein OD, Elisseeff JH, Trexler MM.

Biomaterials. 2012 Nov;33(33):8286-95. doi: 10.1016/j.biomaterials.2012.07.062. Epub 2012 Aug 21.

PMID:
22920579
11.

Taking TASS to task.

Gottsch JD, Schein OD.

Ophthalmology. 2012 Jul;119(7):1295-6. doi: 10.1016/j.ophtha.2012.05.010. No abstract available.

PMID:
22749087
12.

Lessons learned: wrong intraocular lens.

Schein OD, Banta JT, Chen TC, Pritzker S, Schachat AP.

Ophthalmology. 2012 Oct;119(10):2059-64. doi: 10.1016/j.ophtha.2012.04.011. Epub 2012 Jun 14.

PMID:
22704833
13.

Population based outcomes of cataract surgery in three tribal areas of Andhra Pradesh, India: risk factors for poor outcomes.

Khanna RC, Pallerla SR, Eeda SS, Gudapati BK, Cassard SD, Rani PK, Shantha GP, Chakrabarti S, Schein OD.

PLoS One. 2012;7(5):e35701. doi: 10.1371/journal.pone.0035701. Epub 2012 May 2.

14.

Routine preoperative medical testing for cataract surgery.

Keay L, Lindsley K, Tielsch J, Katz J, Schein O.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD007293. doi: 10.1002/14651858.CD007293.pub3. Review.

15.

Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries.

Keay L, Gower EW, Cassard SD, Tielsch JM, Schein OD.

Ophthalmology. 2012 May;119(5):914-22. doi: 10.1016/j.ophtha.2011.11.023. Epub 2012 Jan 31.

16.

Moxifloxacin in situ gelling microparticles-bioadhesive delivery system.

Guo Q, Aly A, Schein O, Trexler MM, Elisseeff JH.

Results Pharma Sci. 2012 Sep 25;2:66-71. doi: 10.1016/j.rinphs.2012.09.002. eCollection 2012.

17.

Hospital benchmarking: are U.S. eye hospitals ready?

de Korne DF, van Wijngaarden JD, Sol KJ, Betz R, Thomas RC, Schein OD, Klazinga NS.

Health Care Manage Rev. 2012 Apr-Jun;37(2):187-98. doi: 10.1097/HMR.0b013e31822aa46d.

PMID:
21799431
18.

Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study.

Keay LJ, Gower EW, Iovieno A, Oechsler RA, Alfonso EC, Matoba A, Colby K, Tuli SS, Hammersmith K, Cavanagh D, Lee SM, Irvine J, Stulting RD, Mauger TF, Schein OD.

Ophthalmology. 2011 May;118(5):920-6. doi: 10.1016/j.ophtha.2010.09.011. Epub 2011 Feb 4.

19.

Punctal occlusion for dry eye syndrome.

Ervin AM, Wojciechowski R, Schein O.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD006775. doi: 10.1002/14651858.CD006775.pub2. Review.

20.

Trends in fungal keratitis in the United States, 2001 to 2007.

Gower EW, Keay LJ, Oechsler RA, Iovieno A, Alfonso EC, Jones DB, Colby K, Tuli SS, Patel SR, Lee SM, Irvine J, Stulting RD, Mauger TF, Schein OD.

Ophthalmology. 2010 Dec;117(12):2263-7. doi: 10.1016/j.ophtha.2010.03.048. Epub 2010 Jun 29.

PMID:
20591493
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk